Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin β6

被引:130
作者
Azare, Janeen
Leslie, Kenneth
Al-Ahmadie, Hikmat
Gerald, William
Weinreb, Paul H.
Violette, Shelia M.
Bromberg, Jacqueline
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Biogen Idec Inc, Cambridge, MA 02142 USA
关键词
D O I
10.1128/MCB.02404-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The persistent activation of signal transducer and activator of transcription 3 (Stat3) is a common feature of prostate cancer. However, little is known about the Stat3 targets that may mediate prostate tumorigenesis. The introduction of an activating mutant form of Stat3 (Stat3-C) into immortalized prostate epithelial cells resulted in tumorigenesis. Stat3-C-expressing cells had decreased E-cadherin levels, increased numbers of lamellipodia and stress fibers, and enhanced migratory capacities compared to vector control-expressing cells, with a concomitant increase in the expression of integrin 06 and its ligand, fibronectin (FN). Exogenously added FN increased cellular migration, with a concomitant loss of E-cadherin expression. The blockade of integrin alpha v beta 6 in S tat3-C-expressing cells inhibited migration, increased E-cadherin levels, and reduced colony formation in soft agar. These results demonstrate the sufficiency of constitutively activated Stat3 in mediating prostate tumorigenesis and identify novel Stat3 targets that are involved in promoting cell migration and transformation.
引用
收藏
页码:4444 / 4453
页数:10
相关论文
共 62 条
  • [41] Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin
    Ng, DCH
    Lin, BH
    Lim, CP
    Huang, GC
    Zhang, T
    Poli, V
    Cao, XM
    [J]. JOURNAL OF CELL BIOLOGY, 2006, 172 (02) : 245 - 257
  • [42] Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma
    Ni, ZY
    Lou, W
    Lee, SO
    Dhir, R
    DeMiguel, F
    Grandis, JR
    Gao, AC
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04) : 1859 - 1862
  • [43] Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
    Niu, GL
    Wright, KL
    Huang, M
    Song, LX
    Haura, E
    Turkson, J
    Zhang, SM
    Wang, TH
    Sinibaldi, D
    Coppola, D
    Heller, R
    Ellis, LM
    Karras, J
    Bromberg, J
    Pardoll, D
    Jove, R
    Yu, H
    [J]. ONCOGENE, 2002, 21 (13) : 2000 - 2008
  • [44] A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells
    O Flowers, L
    Subramaniam, PS
    Johnson, HM
    [J]. ONCOGENE, 2005, 24 (12) : 2114 - 2120
  • [46] Transformation fingerprint: induced STAT3-C, v-Src and Ha-Ras cause small initial changes but similar established profiles in mRNA
    Paz, K
    Socci, ND
    van Nimwegen, E
    Viale, A
    Darnell, JE
    [J]. ONCOGENE, 2004, 23 (52) : 8455 - 8463
  • [47] Cell migration: Integrating signals from front to back
    Ridley, AJ
    Schwartz, MA
    Burridge, K
    Firtel, RA
    Ginsberg, MH
    Borisy, G
    Parsons, JT
    Horwitz, AR
    [J]. SCIENCE, 2003, 302 (5651) : 1704 - 1709
  • [48] Disruption of STAT3 signaling leads to tumor cell invasion through alterations of homotypic cell-cell adhesion complexes
    Rivat, C
    De Wever, O
    Bruyneel, E
    Mareel, M
    Gespach, C
    Attoub, S
    [J]. ONCOGENE, 2004, 23 (19) : 3317 - 3327
  • [49] Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer
    Roessler, M
    Rollinger, W
    Palme, S
    Hagmann, ML
    Berndt, P
    Engel, AM
    Schneidinger, B
    Pfeffer, M
    Andres, H
    Karl, J
    Bodenmüller, H
    Rüschoff, J
    Henkel, T
    Rohr, G
    Rossol, S
    Rösch, W
    Langen, H
    Zolg, W
    Tacke, M
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6550 - 6557
  • [50] RHO-GTPases and cancer
    Sahai, E
    Marshall, CJ
    [J]. NATURE REVIEWS CANCER, 2002, 2 (02) : 133 - +